Abstract
A novel NRF2-βTrCP Protein-Protein Interaction (PPI) inhibitor suppresses lipopolysaccharide-mediated inflammation through the activation of transcription factor NRF2.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have